Infantile Sweet syndrome following MMRV vaccine

Sapir Itzhaki Gabay; Benzion Samueli; Gidon Test; Yuliya Valdman-Grinshpoun; Amir Horev

doi:10.1111/pde.15162

Infantile Sweet syndrome following MMRV vaccine

Pediatr Dermatol. 2023 Jan;40(1):207-209. doi: 10.1111/pde.15162. Epub 2022 Nov 13.

Authors

Sapir Itzhaki Gabay^{1

2}, Benzion Samueli^{2

3}, Gidon Test⁴, Yuliya Valdman-Grinshpoun^{1

2}, Amir Horev^{2

5}

Affiliations

¹ Department of Dermatology, Soroka University Medical Center, Beer-Sheva, Israel.
² Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
³ Department of Pathology, Soroka University Medical Center, Beer-Sheva, Israel.
⁴ Pediatric Emergency Department, Soroka University Medical Center, Beer-Sheva, Israel.
⁵ Pediatric Dermatology Service, Soroka University Medical Center, Beer-Sheva, Israel.

PMID: 36373208
DOI: 10.1111/pde.15162

Abstract

Sweet syndrome (SS), also called acute febrile neutrophilic dermatosis, is rare in the pediatric population, especially in infants and neonates. We present a case of infantile SS that developed 1 day after the MMRV vaccine; we suggest a possible causal relationship between the MMRV vaccine and SS.

Keywords: MMRV vaccine; Sweet syndrome; acute febrile neutrophilic dermatosis; hypersensitivity reaction; vaccine-induced skin reaction.

Publication types

Case Reports

MeSH terms

Chickenpox Vaccine
Child
Humans
Infant
Infant, Newborn
Measles-Mumps-Rubella Vaccine
Sweet Syndrome* / etiology
Vaccines, Combined

Substances

measles, mumps, rubella, varicella vaccine
Measles-Mumps-Rubella Vaccine
Chickenpox Vaccine
Vaccines, Combined